X
Consumer Discretionary, Automotive Mar 14, 2022 09:58 AM (GMT+8) · EqualOcean
Yiouda health learned on the 14th that recently, biaojing Biotechnology Co., Ltd. (hereinafter referred to as "biaojing") announced the completion of ten million yuan seed round financing. This round of financing is invested by new Henglida capital alone, and Riemann conjecture acts as the exclusive financial adviser of this round of financing. With the world's only core patented technology of targatt animal mammary gland reactor, Biaoxing has built a world-class rabbit mammary gland bioreactor, that is, the R & D and production platform of MRP (modernized rabbit pharmacy) protein drugs and protein products. The core technology uses the deoxyribonucleic acid (DNA) and integrase system with specific recognition between bacteria and phages to accurately, efficiently and completely insert large pieces of target protein DNA (i.e. products) into animal genome. After this round of financing, the funds obtained by Biao competitive will be mainly used for platform construction and promote the development of existing product pipelines.

This text is a result of machine translation.